This Marijuana Stock Is Poised for a Breakout Year in 2018 -- Here's What You'll Want to Know About It

Admittedly, 2017 so far has kind of been a ho-hum year for former high-flying marijuana stock GW Pharmaceuticals (NASDAQ: GWPH). For the most part, investors have just been waiting for the next big event for the cannabinoid-focused biotech. GW Pharmaceuticals CEO Justin Gover doesn't think they'll have to wait much longer.

Speaking at the Piper Jaffray Healthcare Conference on Wednesday, Gover stated that 2018 will be "a breakout year" for GW Pharmaceuticals. And that should just be the beginning. Here are three things Gover said at the conference that you'll definitely want to know about this marijuana stock that could be ready to roar again.

Image source: Getty Images.

Source: Fool.com